Sydys Corp. Announces Publication of Phase 2b CVac™ Data Against Ovarian Cancer in Journal for ImmunoTherapy of Cancer SEATTLE, May 18, 2016 (GLOBE NEWSWIRE) -- Sydys Corporation (OTCQB:SYYC), a clinical stage biotechnology company focused on the development of immunotherapies, today announced the publication of...